AstraZeneca
confirmed objective response rate | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
40 of 43
Related slides by other companies
MindMed
Investor Presentation
November 2024
continued response and remission through week with clinical responder rate and clinical remission rate | MindMed
Aeglea BioTherapeutics
Investor Presentation
August 2020
demonstrates durable clinical response at week analysis | Aeglea BioTherapeutics
BioAtla
Investor Presentation
January 2024
phase cab non squamous | BioAtla
MindMed
Investor Presentation
December 2024
continued response and remission through week with clinical responder rate and clinical remission rate | MindMed
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights